Skip to main content

Table 1 Demographic and clinical characteristics

From: Synergistic efficacy of repetitive peripheral magnetic stimulation on central intermittent theta burst stimulation for upper limb function in patients with stroke: a double-blinded, randomized controlled trial

 

rPMS + iTBS

sham rPMS + iTBS

p-value

Age

51.4 ± 12.1

55.6 ± 10.3

0.326b

Sex

Male

Female

  

0.021a

4 (28.6%)

11 (78.6%)

 

10 (71.4%)

3 (21.4%)

 

Stroke stage

  

0.705a

Subacute

8 57.1%)

7 (50.0%)

 

Chronic

6 (42.9%)

7 (50.0%)

 

Stroke side

Left

Right

  

0.705a

6 (42.9%)

7 (50.0%)

 

8 (57.1%)

7 (50.0%)

 

Stroke location

Subcortical

Cortical

Combined

  

0.838a

7 (50.0%)

9 (64.3%)

 

6 (42.9%)

4 (28.6%)

 

1 (7.1%)

1 (7.1%)

 

Stroke type

Hemorrhage

Infarction

  

0.695a

8 (57.1%)

10 (71.4%)

 

6 (42.9%)

4 (28.6%)

 

Aphasia

Yes

No

  

1.000 a

2 (14.2%)

2 (14.3%)

 

12 (85.7%)

12 (85.7%)

 

MMSE

23.4 ± 8.5

27.8 ± 2.8

0.075b

NIHSS

9.9 ± 6.5

8.6 ± 5.3

0.594b

MAS

1.1 ± 0.8

1.1 ± 0.7

0.432b

Brunnström-UEp

3.5 ± 1.1

3.5 ± 0.9

1.000b

Brunnström-UEd

3.3 ± 1.1

3.6 ± 1.4

0.474b

  1. Data are presented as mean ± standard deviation or number (%);aChi-square test or Fisher’s exact test; bIndependentt-test; MMSE: Mini-MentalState Exam; NIHSS: National Institutes of Health Stroke Scale; MAS: Modified Ashworth Scale; Brunnström-UEp: Brunnström Stage-proximal; Upper Extremity; Brunnström-UEd: Brunnström Stage-distal Upper Extremity